Antitumor actions of a chromone glucoside cnidimoside a isolated from Cnidium japonicum

Journal of Natural Medicines

Volumn 62, Issue 3, 2008, Pages 308-313

  Kimura, Yoshiyuki ^a   Sumiyoshi, Maho ^a   Taniguchi, Masahiko ^b   Baba, Kimiye ^b  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Antitumor action; Cnidimoside A; Colon 26; Immune function; Small intestine

Indexed keywords

ANTINEOPLASTIC AGENT; CNIDIMOSIDE A; CNIDIUM JAPONICUM EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CNIDIUM; CNIDIUM JAPONICUM; COLON TUMOR; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG ISOLATION; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CHROMONES; CNIDIUM; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; ENDOTHELIUM, VASCULAR; GLUCOSIDES; HUMANS; INTERFERON TYPE II; INTESTINE, SMALL; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; UMBILICAL VEINS;

EID: 44949171501     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-008-0242-3     Document Type: Article

References (20)

1. Kimura Y, Baba K (2003) Antitumor and antimetastatic activities of Angelica keiskei roots, Part 1: isolation of an active substance, xanthangelol. Int J Cancer 106: 429-437
2. Kimura Y, Taniguchi M, Baba K (2004) Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots. Planta Med 70:211-219
3. Baba K, Kawanishi H, Taniguchi M, Kozawa M (1994) Chromone glucoside from Cnidium japonicum. Phytochemistry 35:221-225
4. Kimura Y, Okuda H (2001) Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 131:1844-1849
5. Kimura Y, Sumiyoshi M (2005) Antitumor and antimetastatic actions of eicosapentaenoic acid ethylester and its by-products formed during accelerated stability testing. Cancer Sci 96:441-450
6. Folkman J (2006) Angiogenesis. Annu Rev Med 57:1-18
7. Folkman J (2006) Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action. Exp Cell Res 312:594-607
8. Folkman J (2007) Is angiogenesis an organizing principle in biology and medicine? J Predatr Surg 42:1-11
9. Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235:442-447
10. Klagsbrun M, D'Amore PA (1991) Regulators of angiogenesis. Annu Rev Physiol 53:217-239
11. Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267:10931-10934
12. Hock H, Dorsch M, Kunzenforf Y, Quin Z, Diamanstein T, Blanskenstein T (1993) Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin4, interleukin 7, tumor necrosis factor, or interferon γ. Proc Natl Acad Sci USA 90:2774-2778
13. + T cell in the antitumor immune response. J Exp Med 188:2357-2368
14. + T cells mediated tumor rejection. J Immunol 168:1-4
15. Colomno HP, Forni G (1994) Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Imuno Today 15:48-51
16. Ma H-L, Whitters MJ, Konz RF, Senices M, Young DA, Grusby MJ, Collins M, Dunussi-Joannopoulos K (2003) IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perfolin but are independent of IFN-γ. J Immunol 171:608-615
17. Iigo M, Kuhara T, Ushida Y, Sekine K, Moore MA, Tsuda H (1999) Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin Exp Metastasis 17:35-40
18. Wang W-P, Iigo M, Sato J, Sekine K, Adachi, Tsuda H (2000) Activation of intestinal mucosal immunity in tumor bearing mice by lactoferrin. Jpn J Cancer Res 91:1022-1027
19. Markovic SN, Murasko DM (1991) Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma. Cancer Res 51:1124-1128
20. Lasek W, Feleszko W, Golab J, Stoklosa T, Marczak M, Darbrowska A, Malejczyk M, Jakobisiak M (1997) Antitumor effects of the combination immunotherapy with interleukin-12 and tumor necrosis factor α in mice. Cancer Immunol Immunother 45:100-108